Cargando…
Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes
Simvastatin, a HMG-CoA reductase inhibitor, is prescribed worldwide to patients with hypercholesterolemia. Although simvastatin is well tolerated, side effects like myotoxicity are reported. The mechanism for statin-induced myotoxicity is still poorly understood. Reports have suggested impaired mito...
Autores principales: | Smith, Robert, Solberg, Rigmor, Jacobsen, Linn Løkken, Voreland, Anette Larsen, Rustan, Arild Christian, Thoresen, G. Hege, Johansen, Harald Thidemann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3885717/ https://www.ncbi.nlm.nih.gov/pubmed/24416446 http://dx.doi.org/10.1371/journal.pone.0085721 |
Ejemplares similares
-
Correction: Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes
Publicado: (2014) -
Nuclear Legumain Activity in Colorectal Cancer
por: Haugen, Mads H., et al.
Publicado: (2013) -
Correction: Nuclear Legumain Activity in Colorectal Cancer
por: Haugen, Mads H., et al.
Publicado: (2013) -
Chronic treatment with terbutaline increases glucose and oleic acid oxidation and protein synthesis in cultured human myotubes
por: Skagen, Christine, et al.
Publicado: (2021) -
Legumain Regulates Differentiation Fate of Human Bone Marrow Stromal Cells and Is Altered in Postmenopausal Osteoporosis
por: Jafari, Abbas, et al.
Publicado: (2017)